DYNE-101

· Dyne Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DYNE-101, covering 2026-03-05 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1 [Phase 1, Phase 2]

See pricing